AbbVie Stock Drops 12% On Schizophrenia Drug Setback: Should You Buy The Dip?
November 11, 2024 at 15:19 PM EST
AbbVie reports disappointing mid-stage data for its schizophrenia drug.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|